Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

O’Toole says patented medicine pricing policies need to go

Conservative Leader Erin O’Toole released a plan on Tuesday that he said will bolster Canada’s ability to produce critical medicines domestically, while taking aim at patented pricing control policies and appearing to leave the door open to trading Canadians’ data for access to vaccines in the future, as did Israel last year to secure early Pfizer COVID-19 vaccines.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article